V Letra (133.3+33.3) Tablet | Price, Usage, Dosage, Composition, and Brand Substitutes - Fixed-Dose Combination (FDC) Drug
V Letra (133.3+33.3) Tablet
V Letra (133.3+33.3) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Super Speciality (Ranbaxy Laboratories Ltd). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ritonavir, Lopinavir. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 500 (arround $7 US Dollar)| Generic (Salt) Combination : | (Ritonavir+ Lopinavir) |
| Pharma Company : | Super Speciality (Ranbaxy Laboratories Ltd) |
| Brand Label : | V Letra (133.3+33.3) |
| Preparation Type : | Tablet |
| Single Dose : | 1 Tablet |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 10 Tablet |
| Price Unit : | Rs 50 INR (arround $0.7 US Dollar) |
| Price Pack : | Rs 500 INR (arround $7 US Dollar) |
Drug details for V Letra (133.3+33.3)
Usage: Why is this medication prescribed?
The main active ingredients or salts in V Letra (133.3+33.3) are :
Ritonavir
Indication (Prescribed for or used as): Ritonavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Ritonavir is in a class of medications called protease inhibitors. It works by decreasing the amount of HIV in the blood. Although ritonavir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other life-style changes may decrease the risk of transmitting the HIV virus to other people.
For more details on Ritonavir, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ritonavir..
LopinavirIndication (Prescribed for or used as): ?Used in combination with ritonavir as lopinavir+ritonavir fixed dose drug combination for the treatment of HIV infection as first line therapy.
For more details on Lopinavir, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Lopinavir..
V Letra (133.3+33.3) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for V Letra (133.3+33.3), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Lopinavir-133.3 mg Ritonavir-33.3 mg).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
| Brand | Price (Rs.) | Brand | Price (Rs.) |